_Life

English 한국어 Investment Analysis: Hims & Hers Health, Inc. (NYSE: HIMS) 1. Corporate Overview Company Name: Hims & Hers Health, Inc. Headquarters: San Francisco, California, USA (2269 Chestnut Street) Listing & Ticker: New York Stock Exchange (NYSE), Ticker: HIMS 2. Core Business, Products, and Technology Hims & Hers Health is a direct-to-consumer (DTC) telehealth company that connects patients with healthcare professionals and delivers prescription and over-the-counter medications directly to their homes. The business is divided into "Hims" for men and "Hers" for women. Their flagship offerings include treatments for hair loss, erectile dysfunction (ED), dermatology, mental health, and recently, weight loss (which has emerged as a primary revenue driver). The core technological advantage lies in their data-driven, personalized platform combined with a highly pre...

English 한국어 York Space Systems (YSS) - Investor Analysis 1. Company Overview Company Name: York Space Systems, Inc. Headquarters: Denver, Colorado, USA. Listing & Ticker: Listed on the NYSE in early 2026 under the ticker YSS . Summary: Founded in 2012, YSS is a provider of small satellites, components, and turnkey mission operations solutions. After being acquired by AE Industrial Partners in 2022, the company accelerated its growth and built a mass-production system tailored for Low Earth Orbit (LEO) constellations. As of August 2026, its market cap is approximately $1.4 to $1.5 billion. 2. Key Business, Products & Technology Core Business: Designing and mass-manufacturing LEO, GEO, and cislunar satellite platforms for government (defense) and commercial customers. Flagship Products: S-CLASS: A low-cost small satellite platform supporting 85-200kg pa...

NuScale Power (NYSE: SMR) Investment Analysis English 한국어 1. Company Overview Company Name: NuScale Power Corporation Headquarters: 1100 NE Circle Blvd., Suite 350, Corvallis, OR 97330, USA. Market & Ticker: Listed on the New York Stock Exchange (NYSE) under the ticker SMR . Went public in May 2022 via a SPAC merger with Spring Valley Acquisition Corp. 2. Core Business, Products & Technology Core Business: Designing, engineering, and globally deploying Small Modular Reactors (SMRs). Key Product: The 'VOYGR' power plant. Each module generates 77 Megawatts electric (MWe). It is highly scalable, offering configurations of 4 (308 MWe), 6 (462 MWe), or 12 modules (924 MWe). Technological Edge: The first and only SMR to receive Standard Design Approval (SDA) from the U.S. Nuclear Regulatory Commission (NRC). Based on proven Pressurized W...

Eli Lilly (NYSE: LLY) Investment Analysis English 한국어 Company Overview & Market Position Eli Lilly and Company (NYSE: LLY) has firmly established itself as a titan in the global pharmaceutical industry. With a rich history dating back to 1876, the Indianapolis-based company recently shattered records by becoming the first healthcare corporation to surpass a $1 trillion market capitalization. This monumental achievement is largely driven by its visionary pipeline in metabolic diseases, oncology, and immunology. The GLP-1 Revolution The cornerstone of Eli Lilly's current explosive growth lies in its dual GIP/GLP-1 receptor agonist, tirzepatide—marketed as Mounjaro for type 2 diabetes and Zepbound for chronic weight management. The global demand for these therapies has fundamentally reshaped the obesity treatment landscape, creating a robust duopoly alongside Novo Nordisk. In 2025 alone, the combined revenue from these ...